CELESTICA INC (CLS)

Every figure this model derived for CLS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 625,300,000 PaymentsToAcquireProductiveAssets 2026-06-30
cash 535,700,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,574,300,000 AssetsCurrent 2026-06-30
current liabilities 6,179,600,000 LiabilitiesCurrent 2026-06-30
equity 2,479,600,000 StockholdersEquity 2026-06-30
interest expense 62,600,000 InterestExpenseNonoperating 2026-06-30
ocf 1,144,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 15,594,500,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 78,400,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CLS on one particular measure came for.

RatioValue
cash operating margin10.42
current ratio1.33
current ratio reported1.23
deferred revenue growth21.38
dilution pct-2.11
ebit cagr56.01
ebit yoy84.63
ev ebit26.84
ev owner earnings83.51
ev sales2.36
fcf margin3.33
growth cv0.69
interest cover21.88
net debt ebitda0.18
operating margin8.78
owner earnings margin2.82
revenue growth47.3
revenue growth per share50.47
roic39.29
rule of 4056.08
sbc pct revenue0.5

What to be careful about

What this model itself distrusts about CLS's figures. Written by the derivation as it ran, not added afterwards.